Chronic Urticaria: Antihistamines, Omalizumab & Remibrutinib
Hives lasting over six weeks: what independent evidence says about antihistamines, omalizumab, remibrutinib, autoimmune tests and supplements, and who funded it.
Independent, evidence-based research on eczema and atopic dermatitis — supplement and management claims graded against primary studies, no industry spin.
Hives lasting over six weeks: what independent evidence says about antihistamines, omalizumab, remibrutinib, autoimmune tests and supplements, and who funded it.
Aciclovir and penciclovir creams and valaciclovir tablets probably shorten a cold sore by about one day, but the effect is small and most trials were drug-funded.
Baricitinib and ritlecitinib regrow hair in severe alopecia areata while taken, but hair is usually lost after stopping; most other options have weak evidence.
Acne has effective treatments, but the strongest evidence is for topical combinations and isotretinoin. Diet and supplement claims rest on small or sponsored trials.
Athlete’s foot and ringworm: what topical antifungals, oral terbinafine and tea tree oil achieve, with resistance and liver risks graded.
Independent evidence on vitiligo treatments, phototherapy and ruxolitinib cream, plus the funding behind the trials and supplement claims.
Topical steroids rarely thin the skin with short, proper courses. Potent products on thin skin and long use carry the main risk, and the UK withdrawal debate is unresolved.
Regular sunscreen use is linked to less melanoma in a long Australian trial, but the evidence on vitamin D and some chemical filters is less settled.
Creams such as ivermectin and azelaic acid have the best independent support for rosacea bumps, and brimonidine for redness, but most key trials were company-run.
Hidradenitis suppurativa treatments reviewed: biologics, antibiotics and surgery, with the drug-maker funding behind the key trials.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.